Jing Wu
Tianjin University
Jing Wu is listed as Tianjin University. Jing spoke at ISPOR Europe 2026 in November 2026 (moderator, “From Policy to Practice: The Evolution of HEOR and Healthcare Decision-Making in China — Experiences, Insights, and Lessons Learned”). Jing is scheduled to speak at ISPOR Europe 2026 on 10 November 2026.
Compiled from published conference agendas; not yet confirmed by Jing. Is this you? Claim this profile.
About
Prof. Wu has dedicated nearly 20 years to research and teaching in health economics and pharmacoeconomics. Her expertise spans health policy evaluation, pharmacoeconomic evaluation, real-world data analysis, and health-related quality of life and health utility study. She earned her PhD in Pharmacoeconomics through a joint program between Shenyang Pharmaceutical University and Peking University in 2007 and was a visiting scholar at the Schaeffer Center for Health Policy and Economics at the University of Southern California in 2013. Prof. Wu has authored over 100 high-impact scientific articles, led three National Natural Science Foundation of China projects, contributed to multiple pharmacoeconomics textbooks, and spearheaded the development of the China Guidelines for Pharmacoeconomic Evaluations (2020) and the Companion Guide to the China Guidelines for Pharmacoeconomic Evaluations (2022), promoting the development and standardization of pharmacoeconomics in China. She currently ser
Upcoming
ISPOR Europe 2026 8 November 2026 – 11 November 2026
- Bridging China and Europe: When Is China-Generated Evidence Fit for European HTA? Speaker · 10 November 2026
- Shaping the Global Research and Policy Agenda in HEOR in the Next Decade: A Value in Health Regional Issues Forum Speaker · 10 November 2026